| Literature DB >> 33374575 |
Tunde Jurca1, Liza Józsa2,3,4, Ramona Suciu5, Annamaria Pallag1, Eleonora Marian1, Ildikó Bácskay2,3,4, Mariana Mureșan6, Roxana Liana Stan7, Mariana Cevei5, Felicia Cioară5, Laura Vicaș1, Pálma Fehér2,3,4.
Abstract
Topical anti-inflammatory and analgesic effect for the treatment of <span class="Disease">rheumatoid arthritis is of major interest because of their fewer side effects compared to oral therapy. The purpose of this study was to prepare different types of topical formulations (ointments and gels) containing synthetic and natural anti-inflammatory agents with different excipients (e.g.,: surfactants, gel-forming) for the treatment of <span class="Disease">rheumatoid arthritis. The combination of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), diclofenac sodium, a topical analgesic agent methyl salicylate, and a lyophilized extract of Calendula officinalis with antioxidant effect were used in our formulations. The aim was to select the appropriate excipients and dosage form for the formulation in order to enhance the diffusion of active substances and to certify the antioxidant, analgesic, and anti-inflammatory effects of these formulations. To characterize the physicochemical properties of the formulations, rheological studies, and texture profile analysis were carried out. Membrane diffusion and permeability studies were performed with Franz-diffusion method. The therapeutic properties of the formulations have been proven by an antioxidant assay and a randomized prospective study that was carried out on 115 patients with rheumatoid arthritis. The results showed that the treatment with the gel containing diclofenac sodium, methyl salicylate, and lyophilized Calendula officinalis as active ingredients, 2-propenoic acid homopolymer (Synthalen K) as gel-forming excipient, distilled water, triethanolamine, and glycerol had a beneficial analgesic and local anti-inflammatory effect.Entities:
Keywords: Calendula officinalis extract; anti-inflammatory agent; antioxidant; diclofenac sodium; methyl salicylate; rheumatoid arthritis; surfactants; topical formulation
Mesh:
Substances:
Year: 2020 PMID: 33374575 PMCID: PMC7793088 DOI: 10.3390/molecules26010024
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411